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Schiff base ligands comprising heterocyclic moieties deserve distinct consideration because of their excellent 
chemotherapeutic and antioxidant properties as biologically active agents. In present investigation, two novel heterocyclic 
triazole derived Schiff base ligands have been synthesized using 3-chlorobenzaldehyde (L1), 4-methoxybenzaldehyde (L2) 
with 1H-1,2,4-triazol-3-amine backbone that are biologically active. Mn(II) complexes have been synthesized by combing 
ligands in 1:2 molar ratio (metal:ligand), their structure and bonding nature are recognised by respective physical, spectral 
and analytical data. The ligands (L1 & L2) and their metal complexes are characterized by elemental analyses, electronic, 
FT-IR, 1H and 13C NMR and EPR spectroscopy techinques. Antimicrobial activity of the synthesized L1, L2 and their metal 
complexes are tested against Bacillus subtilis (Gram-positive, catalase-positive bacterium) as well as Fungi namely Phylium 
Aphanidematum, Macrophomina phasiolina, Fusarium oxysporum. Both the ligands and metal complexes exhibit excellent 
antimicrobial activity under low inhibitory concentration such MIC ≤ 250 μg/mL. Upon co-ordination, antimicrobial 
properties have been enhanced by 21%. The anticancer activity of the synthesized complex has been investigated against 
human tumour cell lines (Breast cancer MCF-7 cells) demonstrated that L1M complex displays potent inhibition against 
MCF-7. Using this molecular docking study, we can predict the complex–biomolecular interaction and it plays vital role in 
the drug discovery and also it is a step by step process which is used to place synthesised compounds into the binding sites 
of the DNA molecule. Further, Molecular DNA docking results demonstrated encouraging responses, thereby opening up 
new avenues for the application of the synthesized inorganic triazole derivative complexes as leads for the development of 
novel anti-cancer drugs. 
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Triazoles and their derivatives have attracted 
immensely specific research interest in modern 
heterocyclic chemistry in the view of their substantial 
pharmacological and biological activities1. In 
particular, 1,2,4-triazole derived Schiff base ligands 
regulate the growth of many harmful micro-organisms 
and possess excellent antibacterial, antiviral, 
antioxidant and anti-inflammatory properties, hence 
appropriate to be used as biocides2-4. According to the 
World Health Organisation report millions of peoples 
were died due to the infections caused by the micro-
organisms like fungi, virus, bacteria etc.5. The 
antibiotics must be less toxic for healthy cells and 
must have maximum efficiency towards killing the 
micro organisms6–8. In the recent years, there are 
some restricted antibiotics which can cause the failure 
in the antimicrobial therapy and also the rate of curing 
capability is also high with maximum cost9–16. 
Usually, Gram-positive bacteria specialized in the 
extrusion of different doubted substance in the out of 
the cell wall (efflux bomb); the limited access of the 
antimicrobial agents to its miserable site of exchange 
is always active one. So, it should be a good antibiotic 
drug17. The antibiotics having metal complexes are 
more active towards the microbial studies. 
Specifically transition metal complexes, having low 
molecular weight can be used to response for the 
probable structural property and also it has more 
potential activity towards the microorganisms18–20. 
Manganese complexes are easily binds with protein 
and form metal-protein complexes and also exhibits 
great biological active results. These types of 
complexes easily exchange the electrons and store 
the ions which creates the enormous interests in 
INDIAN J CHEM, SEC A, JUNE 2021 798
synthesise of manganese containing complexes with 
low molecular weight21. Also, manganese derivatives 
have been reported to be used for environmental, 
industrial and agricultural applications. Not only has 
an upsurge of importance taken place in experimental 
studies, but there has also been a repeated concern in 
the structural elucidation of manganese complexes.  
Several Schiff bases are reported to possess 
remarkable antibacterial, antifungal, and anticancer 
activities22. In such class of compounds, the 
C=N moiety is important for biological activity. 
Abdel-Rahman et al.22 have reported number of 
transition metal complexes by using variety of 
Schiff base ligands and have studied their different 
biological activities such as antimicrobial, anticancer, 
antifungal, etc. Triazole derived Schiff base ligand 
Mn(II) complex 2-[(1Z)-N-(1H-1,2,4-triazol-3-yl)-
etanimidoyl]phenol was synthesized by condensation 
of 3-amino-1,2,4-triazole with 2-hydroxyacetophenone 
and demonstrated as an efficient antibacterial agent 
against several bacterial strains: Escherichia coli, 
Salmonella typhi, Bacillus subtilis, Klebsiella 
pneumonia, and Staphylococcus aureus by Summara  
et al23. The synthesis and characterization of divalent 
transition metal complexes e.g., Co(II), Cu(II), Cd(II) 
and Mn(II) with nicotinohydrazide ligand was reported 
by Shen et al.24. The complex also used for in vitro cell 
experiment to test the antitumour effect. The results 
revealed that the uncomplexed ligand show cytotoxic 
effect than the metal complexes. Metal complexes can 
effectively decrease the proliferation rate of different 
type of cancerous cell line like human gastric cancer 
cells, human esophageal cancer cell line (ECA109). 
Anticancer activity of the synthesized Mn(III), Zn(II) 
and Pt(II) macroacyclic complexes against human 
gastric (AGS, IBRC C 10071) and lung (A549; IBRC 
C10080) cell lines.25 Ispir et al.26 described the Schiff 






yl)ethylideneamino)-1H-pyrazol-3(2H)-one ] and their
Co(II), Cu(II), Ni(II), Mn(II) and Cr(III) complexes
exhibit antibacterial and antifungal activities against E.
coli, Staphylococcus aureus, Klebsiella pneumoniae,
Mycobacterium smegmatis, P. aeruginosa, 
Enterobacter cloacae, and Micrococcus leteus26. Four
new Mn(III) Schiff base complexes were synthesized
and characterized. The complexes have general
formula [MnClLx] in which L represents a Schiff base 
ligand derived from condensation of meso-1,2-
diphenyl-1,2-ethylenediamine with salicylaldehyde or 
its 3-OMe-, 5-Br-, or 5-OMe-derivatives (x = 1–4, 
respectively). The crystal structure of [MnClL1] was 
characterized by X-ray crystallography. The in vitro 
anticancer activity of these complexes was evaluated 
by MTT and apoptosis assays against human breast 
(MCF-7) and liver (Hep G2) cancer cells. The 
complexes exhibited considerable antiproliferative 
activity against both cell lines (IC50 = 10.8–21.02 μM). 
Docking simulations using AUTODOCK were also 
carried out. The results showed that all complexes 
fitted into the minor groove region of DNA27. 
In the light of the foregoing, this work aimed to 
prepare two new class of triazole derived Schiff base 
ligands using benzene derivatives of 
3-chlorobenzaldehyde (L1), 4-methoxybenzaldehyde
(L2) with 1H-1,2,4-triazol-3-amine. The Schiff base
ligand act as bidentate and coordinate with manganese
in the ratio of 2:1 (ligand:metal). These ligands can
form 3-member chelating ring. In the present studies,
manganese has been focussed due to their smaller size
and comparatively higher nuclear charge.
The synthesised metal complexes treated with the 
gram positive Bacillus subtilis and gives efficient 
activity. Anticancer cell line testing with MCF 7 
studies indicated that these complexes arrested the 
cell cycle efficiently and promoted tumour cell 
destruction via a reactive oxygen species (ROS)-
mediated mitochondrial pathway. 
Materials and Methods 
The chemicals 3-chlorobenzaldehyde, 4-
methoxybenzaldehyde, 1H-1,2,4-triazol-3-amine, 
Manganese chloride were purchased from Sigma-
Aldrich and used without further purification. The 
solvents were purchased from the Merck used after 
purification using suitable distillation procedures. 
Physical measurements 
Elemental analyses (C, H, N and S) were carried 
out using elemental various EL III CHNOS elemental 
analyser. Fourier transform infrared (FT-IR) spectra 
the compounds were recorded using Shimadzu 
8400S FT-IR spectrophotometer in the range of 
4000-400 cm-1 using KBr pellets. Electronic 
spectra were recorded using Shimadzu UV-2450 
spectrophotometer. The X-band of electron 
paramagnetic resonance (EPR) spectra of Mn(II) 
complexes in the acetonitrile were recorded at the 




room temperature, tetracyanoetylene as the g (2.0027) 
marker. 1H and 13C NMR spectrums were recorded for 
ligands (L1 & L2) on Varian XL-200 NMR 
instrument using deuterated DMSO solvent. 
 
Molecular docking studies 
Molecular docking is one of the clear theoretical 
study for determining the binding energy of our 
synthesised compounds with biomolecules like DNA 
and proteins. The molecular structures of the Mn(II) 
complexes converted into moles files using mercury 
V3.6. The mol files of the synthesised  
Mn(II) complexes were optimized using Gaussian 09 
computational suite with the basis set of LanL2DZ. 
The crystal structures of DNA hexamer 
d(CGATCG)2 (PDB ID: 1Z3F) was downloaded from 
protein data bank (http://www.rcsb.org/pdb) in PDB 
format. Discovery studio software was used to delete 
the ligand and water molecule already present in the 
biomolecules. The docking studies for L1 and L2 
were carried out using Autodock vina program and 
the complexes were prepared using Autodock tools 
1.5.6. The grid map value was set to be  
120 × 120 × 120 Å for xyz axis grid spacing value of 
0.680 Å for DNA.  
 




A mixture of M-chlorobenzaldehyde (1 mmol) and 
3-amino-1,2,4-triazole (1 mmol) was dissolved in  
10 mL of ethanol which was continuously stirred and 
refluxed for 4 h in an oil bath at 60 ºC. The compound 
was then allowed to evaporate at the room 
temperature. The yellow coloured product obtained 
was washed with diethyl ether and chloroform. Then 
the yellow solid was recrystallized using ethanol. 
Purity of the compound was checked by thin layer 
chromatography. Chemical formula: C9H7ClN4; 
elemental analysis (%): C, 52.31; H, 3.41; Cl, 17.16; 
N, 27.11; IR (KBr pellets, υ, cm-1): 1650 (C=N), 1340 
(Ar-H), 1596 (N-H); UV-visible absorption [(λmax, 
nm), solvent, acetonitrile: chloroform (1:1) mixture]: 
375, 328, 272 and 218. 
 
Synthesis of L1M metal complex 
In the preparation of Mn(II) complex, 5 mL 
ethanolic solution of L1 and manganese chloride were 
mixed with 2:1 ratio at 70 ºC using oil bath. The 
content was then kept for evaporation. The sandal 
coloured solid metal complex obtained was washed 
with ethanol and water. The ligand L1 and metal 
complex L1M were synthesized as given in Scheme 1. 
Chemical formula: C18H14Cl4MnN8; elemental 
analysis (%): C, 40.10; H, 2.62; N, 20.79; IR (KBr 
pellets, υ, cm-1): 1642 (C=N), 1345 (Ar-H), 1573 (N-
H); UV-visible absorption [(λmax, nm), solvent, 




Anisaldehyde (1 mmol) and 3-amino-1,2,4-triazole 
(1 mmol) were dissolved in 10 mL of 
acetonitrile:ethanol mixture (1:1) which was 




Scheme 1 — Reaction pathway for L1 and L1M complexes 




compound was then allowed to evaporate in the 
dedicator for 48 h. The light yellow coloured product 
obtained and washed cold ethanol. Chemical formula: 
C10H10N4O; elemental analysis (%): C, 59.40; H, 4.98; 
N, 27.71; O, 7.91; IR (KBr pellets, υ, cm-1): 1608 
(C=N), 1358 (Ar-H), 1583 (N-H); UV-visible 
absorption [(λmax, nm), solvent, acetonitrile:chloroform 
(1:1)]: 370, 322, 265 and 217. 
 
Synthesis of L2M metal complex 
For the synthesis of L2M complex, manganese 
chloride was dissolved in 2 mL of water and added 
dropwise in 5 mL ethanolic solution of L2 and the 
mixture was refluxed for 6 h and then kept for 
evaporation. The light yellow coloured solid metal 
complex obtained was washed with cold ethanol and 
water. The synthesis of ligand L2 and metal complex 
L2M were shown in Scheme 2. Chemical formula: 
C20H20Cl2MnN8O2, elemental analysis (%): C, 45.30; 
H, 3.80; N, 21.13; O, 6.03. IR (KBr pellets, υ, cm-1): 
1648 (υ C=N), 1354 (υ Ar-H), 1562 (υ N-H); UV-
visible absorption [(λmax, nm), solvent, DMSO]: 595, 
484, 340 and 235. 
 
Preparation of the microbial culture 
The antibiotic tetracyclin was used as a standard in 
the microbial study and Bacillus subtilis as a gram 
positive bacterium used as the test organism in the 
yeast surface. The bacteria and the yeast strain were 
mixed into the nutrient broth (Difco) and malt extract 
and incubated for more than 48 h. Using disc 
diffusion method the sterile Mueller Hinton Agar for 
bacteria and sabouraud dextrose agar for the yeast 
surface preparation. The synthesised compounds were 
dissolved in the DMF solvent as 40 (g/disc) solutions 
and the antibiotic tetracyclin were placed in near the 
wall (6 mm diameter). The medium was kept under 
the incubate condition of 32 ºC for 48 h. 
 
Anticancer cell culture  
The monolayer cell culture was trypsinized and the 
cell count was adjusted to 5.0 × 105 cells/mL using 
respective media containing 10% FBS. To each well 
of the 96 well microtiter plate, 100 μL of the diluted 
cell suspension (50,000 cells/well) was added. After 
24 h, when a partial monolayer was formed, the 
supernatant was flicked off, the monolayer was 
washed once with medium and 100 μL of different 
test concentrations of test drugs were added on to the 
partial monolayer in microtiter plates. The plates were 
then incubated at 37 ºC for 24 h in 5% CO2 
atmosphere. After incubation the test solutions in the 
wells were discarded and 100 μL of MTT (5 mg/10 
mL of MTT in PBS) was added to each well. The 
plates were incubated for 4 h at 37 ºC in 5% CO2 
atmosphere. The supernatant was removed and  
100 μL of DMSO was added and the plates were 
gently shaken to solubilize the formed formazan. The 
absorbance was measured using a microplate reader at 
a wavelength of 590 nm. The percentage growth 
inhibition was calculated using the following formula 
and concentration of test drug needed to inhibit cell 
growth by 50% (IC50) values is generated from the 
dose-response curves for each cell line.  
 
Results and Discussion 
Characterisation of compounds 
The analytical data for the L and metal complexes 
were listed in the synthesis part. The vibrational 




Scheme 2 — Reaction pathway for L2 and L2M complexes 
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organic part and also the functionality which involves 
the coordination for the metal complex formation. In 
Supplementary Data, Fig. S1(a) shows for L1 the 
peak at the range of 1650 cm-1 represents the C=N 
functionality and also 1340, 1596 cm-1 peaks denotes 
the aromatic ring and the N-H, respectively. Ligand 
L2 having FT-IR peak at 1648 cm-1 for C=N group 
denotes the Schiff base formation. A shift in the C=N 
peak value to 1642 & 1648 cm-1 for complex 1 & 2, 
respectively, confirms the participation of C=N group 
in metal coordination as shown in Supplementary 
Data, Fig. S1(b). The 1H and 13C NMR taken in 
DMSO solvent for ligands L1 and L2 are shown in 
Fig. 1. For L1, the 1H NMR shows peak at 10.9 ppm 
range due to the proton present in the C=N 
(azomethine), the proton of the triazole ring and the 
benzene ring covers the area of 7.4-8.4 ppm range. 
The 13C NMR also shows 192 ppm range peak for the 
azomethine formation and the proton counting covers 
the total carbon atoms present in the system. In the 
case of L2, the proton at 7.51 ppm denotes the 
azomethine formation and at 162 ppm of 13C NMR 
represents the same functionality. 
The electronic spectra for the ligand and complexes 
were recorded at room temperature using DMSO 
solvent and are shown in Supplementary Data, Fig. S2. 
The bands at 375, 328, 272 and 218 for L1 and bands 
at 370, 322, 265 and 217 nm for L2, can be assigned to 
π-π* transition (Supplementary Data, Fig. S2a). In 
Supplementary Data, Fig. S2b, for the metal complexes 
the peaks at 573, 595 nm and 460, 484 nm are due to 
the 2B2 – 
2B1 and also 
2B2 – 
2E1 transitions, for L1 and 
L2, respectively. The ESR spectra of the Mn(II) 
complexes explains the information about the 
environmental of the central metal ion which 
coordinate with the ligand to form the geometry. The 
ESR spectra of the Mn2+ complexes were taken at room 
temperature and are shown in Fig. 2. The single line of 
the spectrum for L1M, shows the unpaired electron 
with two peaks which denotes that the one is for the 
low field and another is for high field which can be 
used to calculate g‖ and g┴ values. For L1M, gǁ value 
= 2.432 and g┴=1.397 and for L2M, g|| value=2.6390 
and g┴=1.950. Based on the results both complexes 
having gǁ is greater than g┴. These results indicate that 
the complexes are in distorted octahedral arrangement. 
Fig. 1 — 1H NMR spectra for (a) L1, (c) L2, and 13C NMR spectra for (b) L1, (d) L2 





Inorganic complex that liberates free radicals can 
destroy living bacterial cells and cytotoxic potential of 
these compounds are assessed in terms of zone of 
inhibition caused by the effective destruction of 
bacterial colonies. The antibacterial results of the 
synthesised ligands and compounds were reported in 
Table 1. The results show that the ligands and the 
metal complexes were performed against with 
Bacillus subtilis with good activity. The toxicity of 
the compounds were found to be better activity than 
the ligand L1 against the Bacillus subtilis. The 
inhibition plot and the antimicrobial activity images 
were shown in Fig. 3. 
 
Antifungal activity 
Newly synthesized Schiff base L1 and L2 and their 
respective Mn(II) complexes were tested against three 
fungal strains namely Phylium Aphanidematum, 








Fig. 3 — Antibacterial activity images and zone inhibition graphs for (a and b) L1 and its complex, and (c and d) for L2 and its complex,
respectively 




Inhibition rate against each fungi at two different 
concentrations associated with all four compounds are 
tabulated in Supplementary Data, Table S1. From 
results, it is evident that when concentration is 
increased from 100 to 200 ppm, clearly growth rate of 
fungi strain is enhanced irrespective of nature of 
fungus strain. Under the identical experimental 
conditions, chelation with Mn has improved the 
inhibition ability, which is attributed due to influence 
of metal ion upon cellular damage process, which 
could be better explained with in the light of Tweedy's 
chelation theory. Lipophilic character of Mn has been 
enhanced after chelating with ligands due to reduced 
polarity caused by likely delocalisation of p-electrons 
that facilitates permeation through the lipid layers of 
cell membrane of fungi strain. Hence antifungal 
activity has been improved after co-ordination, 
consequently both L1M and L2M displayed enhanced 
rate fungicidal properties in relation to L1 and L2 
approximately by 5%. 
 
Anticancer activity 
The IC50 of a drug can be determined by 
constructing a dose-response curve and examining the 
effect of different concentrations of antagonist on 
reversing agonist activity. IC50 values can be 
calculated for a given antagonist by determining the 
concentration needed to inhibit half of the maximum 
biological response of the agonist. IC50 values for 
cytotoxicity tests were derived from a nonlinear 
regression analysis (curve fit) based on sigmoid dose 
response curve (variable) and computed using Graph 
Pad Prism. The synthesized compounds were treated 
with MCF7 tumour cells. The standard reference 
compound doxorubicin gave the IC50 value of 26.73. 
The complexes L1M and L2M shows IC50 value 
81.86 and 200.6, respectively, as shown in 
Supplementary Data, Table S2. The result shows 
complex L1M shows better activity towards MCF7 




Fig. 4 — Images showing anticancer activities (a, b, c) for L1M and (d, e, f) for L2M using Control, 10 ug/mL, 320 μg/mL of 
compounds, respectively, and (g) plot of concentration versus % inhibition complexes 
 
Table1 — Antibacterial results for L1M and L2M 
Sample  Sample concentration 
(µL) 
Zone of  
inhibition (mm)  
Compound L1M 
Standard Tetracyclin (10 mg/mL) 8  
Control Ethanol NA 
L1 100  5  
L1M 100 7  
Compound L2M 
Standard Tetracyclin (10 mg/mL) 12  
Control Ethanol NA 
L2 100  8  
L2M 100  6  
 




line testing with MCF 7 studies are shown in 
Supplementary Data, Fig. S3, indicated that these 
complexes arrested the cell cycle efficiently and 
promoted tumour cell destruction via a reactive 
oxygen species (ROS)-mediated mitochondrial 
pathway. Further the complexes were evaluated for 
DPPH radical scavenging activity. The IC50 values 
were found to be 0.180, 0.196 mg/mL for L1M, L2M, 
respectively (Supplementary Data, Table S3). 
 
Molecular Docking Studies with DNA 
Many recent reports have described the biological 
applications of Manganese-coordinated complexes 
and pronounced consideration has been paid to their 
excellent potency as anti-tumour drugs. Mode of drug 
binding and its interaction with specific biomolecule 
(DNA/Protein) could be evaluated through molecular 
modelling of drugs. Herein we attempted to provide 
better insight about interaction of synthesised 
complex with DNA that serve as a widely used 
therapeutic target for diseases concerning intracellular 
interactions. In DNA, hydrogen bonding interaction is 
predominantly noticeable for adenine–thymine and 
guanine–cytosine base pairs in the complementary 
double helix structure. Graphical representation of the 
interaction model of complex with DNA is as shown 
in Supplementary Data, Fig. S4. 
Molecular docking studies were performed for 
docking and interaction calculations for categorising 
the probable binding sites for the drug molecules. The 
synthesized Mn(II) complexes used to dock with 
DNA hexamer d(CGATCG)2 (PDB ID: 1Z3F). Using 
this molecular docking study, we can predict the 
complex–biomolecular interaction and it plays vital 
role in the drug discovery and also it is a step by step 
process which used to place synthesised compounds 
into the binding sites of the DNA molecule. The 
complexes exhibit intercalation mode of binding 
towards the DNA molecule by considering the 
binding mode and binding affinity. The binding 
interactions of drug-DNA are -5.9 and -5.5, 
respectively, for complex L1M and L2M. Overall 
results suggests that the synthesized complexes have 
the tendency to bind with the DNA molecule, as L1M 
is having the lowest binding energy value so it 
strongly binds with the DNA molecule (Fig. 5). 
 
Conclusions 
Organometallics based drugs are proposed for 
many therapeutic applications and this study 
attempted a manganese complex as a new drug and 
demonstrated its use for treating MCF7 carcinogenic 
cells. Two novel Schiff base ligands (L1 and L2) and 
based on synthesised ligands Mn(II) co-ordination 
complexes (L1M and L2M) were synthesised. The 
structures of these compounds were elucidated by 
FT-IR, UV-Vis, NMR and ESR characterisation 
techniques. Developed Mn(II) complexes showed 
good oxidative stability along with high antibacterial 
activity when tested against the gram positive 
bacterium Bacillus subtilis. Antifungal activity has 
been improved after co-ordination, consequently 
both L1M and L2M displayed enhanced rate 
fungicidal properties in comparison to L1 and L2 
approximately by 5%. In addition, the results show 
that it is possible to tailor the desired Schiff base 
through condensation with triazole derivative. Using 
the molecular docking study, we can predict the 
complex–biomolecular interaction and it plays vital 
role in the drug discovery and also it is a step by step 
process which used to place synthesised compounds 
into the binding sites of the DNA molecule. The 
 
Table 2 — Anticancer results against MCF-7 cell lines 
Compound Conc. 
(g/mL) 
OD@590 nm % Inhibition IC50 
(g/mL) 
Control 0 0.778 0.00 81.86 
L1M 10 0.741 4.76 
20 0.642 17.48 
40 0.579 25.58 
80 0.455 41.52 
160 0.324 58.35 
320 0.232 70.18 
L2M 10 0.775 0.39 200.6 
20 0.712 8.48 
40 0.671 13.75 
80 0.57 26.74 
160 0.505 35.09 




Fig. 5 — Molecular docking results of (a) L1M and (b) L2M 




synthesised compounds were treated with MCF7 
cancer cell and the L1M shows better activity towards 
the cell line. These studies indicated that these 
complexes arrested the cell cycle efficiently and 
promoted tumour cell destruction via a reactive 
oxygen species mediated mitochondrial pathway. 
Further, Molecular DNA docking results 
demonstrated encouraging responses, thereby opening 
up new avenues for the application of the synthesized 
inorganic triazole derivative complexes as leads for 
the development of novel anti-cancer drugs. 
 
Supplimentary Data 
Supplementary data associated with this article  
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